Search results
Results from the WOW.Com Content Network
Amisulpride is approved and used at low doses in the treatment of dysthymia and major depressive disorder. [10] [20] [11] [21] [22] [23] Whereas typical doses used in schizophrenia block postsynaptic dopamine D 2-like receptors and reduce dopaminergic neurotransmission, low doses of amisulpride preferentially block presynaptic dopamine D 2 and D 3 autoreceptors and thereby disinhibit dopamine ...
It should be administered in a 7-day course with 4 mg/kg given per day for three days, followed by 1.6 mg/kg for three days. Side effects of the drug are few but include potential neurotoxicity developing if high doses are given. [citation needed] Artesunate is a hemisuccinate derivative of the active metabolite dihydroartemisin.
Elmarit-S 1:2.8/30 mm ASPH. CS; Elmarit-S 1:2.8/45 mm ASPH. Elmarit-S 1:2.8/45 mm ASPH. CS; For the Leica L Mount. Elmarit-TL 18 mm f/2.8 ASPH. APO-Macro-Elmarit-TL 60 f/2.8 ASPH. Vario-Elmarit-SL 24-70 f/2.8 ASPH. Vario-Elmarit-SL 1:2.8–4 / 24–90 ASPH. APO-Vario-Elmarit-SL 1:2.8–4 / 90–280; For the Four Thirds mount [a 1] D Vario ...
Package inserts for prescription drugs often include a separate document called a "patient package insert" with information written in plain language intended for the end-user—the person who will take the drug or give the drug to another person, such as a minor. Inserts for over-the-counter medications are also written plainly. [1] [2]
[7] [8] A drug may be classified as second-line instead of first-line for one of three possible reasons: 1) it may be less effective than the first-line drugs (e.g., p-aminosalicylic acid), 2) it may have toxic side-effects (e.g., cycloserine), or 3) it may be effective, but unavailable in many developing countries (e.g., fluoroquinolones ...
Doxylamine is generally safe for administration to healthy adults. Doses of doxylamine of up to 1,600 mg/day for 6 months have been given to adults with schizophrenia, with little toxicity encountered. [33] The median lethal dose (LD 50) is estimated to be 50–500 mg/kg in humans. [34]
Azathioprine is used alone or in combination with other immunosuppressive therapy to prevent rejection following organ transplantation, and to treat an array of autoimmune diseases, including rheumatoid arthritis, pemphigus, systemic lupus erythematosus, Behçet's disease, and other forms of vasculitis, autoimmune hepatitis, atopic dermatitis, myasthenia gravis, neuromyelitis optica (Devic's ...
Eperisone hydrochloride is available as the brand name preparations Myonal and Epry as 50 mg sugar-coated tablets, or as 10% granules for oral administration. [6] An experimental form of the drug, as a transdermal patch system, has shown promising results in laboratory tests on rodents; however, this product is not currently available for human use.